Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride I.P. 3mg + Metformin Hydrochloride (S.R.) I.P. 1000mg Bi-Layered Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹229/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Metfoam G3 Forte Tablet combines Glimepiride 3mg with sustained-release Metformin Hydrochloride 1000mg in a bi-layered tablet. This formulation provides a balanced approach to managing type 2 diabetes mellitus by stimulating insulin secretion and enhancing insulin sensitivity. The sustained-release layer ensures gradual absorption of Metformin, reducing gastrointestinal side effects while maintaining effective blood glucose control throughout the day.
Possible side effects include hypoglycemia, nausea, abdominal discomfort, dizziness, and rare risk of lactic acidosis with Metformin.
Recommended for adults with type 2 diabetes who require both improved insulin secretion and better insulin action to achieve optimal glycemic control.
Take with meals to reduce gastrointestinal discomfort. Regular blood glucose and kidney function monitoring is advised. Not indicated for type 1 diabetes or diabetic ketoacidosis.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This anti-diabetic combination is used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting and post-meal blood sugar control, insulin resistance, and long-term glycemic management. It is widely prescribed by physicians and diabetologists for patients requiring stronger combination therapy with improved compliance due to bi-layered technology.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 3mg + Metformin 1000mg Bi-layered Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, lifelong therapy usage, and steady monthly repeat sales in diabetes care when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.